According to the American Cancer Society, lung cancer continues for 3% of cancer deaths nationwide and across seven percent of cancer cases in the U.S., annually. Breast cancer accounts for nearly one in five cancer deaths. Statistics like these lead researchers to believe that further research into better treatments for cancers could indeed be very profitable to those with the disease.
This field is focused on developing more targeted therapies and delivery systems. In terms of treatments for pancreatic cancer, clinical trials are currently underway in both the U.S. and Europe. In Europe, there is a European Network Of Pancreatic Cancer coordinating research. One clinical trial in the UK involves the use of methotrexate, a drug already in wide use for treating other forms of cancer. Other potential applications include the use of bioresonance therapy, which uses nutrients such as vitamin C and glutathione to fight cancer; platinum protein and iodine therapy, which use existing compounds such as iodine and the protein keratin to encourage the production of a cancer-fighting protein in the body; and chromium picolinate, an antioxidant found in most fruits and vegetables.
Since the studies and clinical trials are in full swing, there is no telling how far the field can go in the future. However, there is plenty of reason for optimism. The market forecast for therapeutic proteins and enzymes targets an exciting future. This is largely due to the fact that current pancreatic cancer treatment only addresses the symptoms, leaving the real causes unchecked and often fatal.
Cancer Metabolism Based Therapeutics attempts to address various metabolic pathways via a multi-disciplinary approach. This is important because metabolism is the basis of cancer, and most cancers are metabolically active. It is also the basis of many diseases, such as diabetes and AIDS. This means that targeting a single pathway can be detrimental to cancer.
Amino Acid Metabolism Based Therapeutics attempts to address all of the metabolic pathways through a comprehensive approach. There are five chapters: The Basic biology of Cancer, Gene regulation, Lipid metabolism, Genetic and gene interactions, Gene transcription and signaling pathways, and amino acid metabolism, just to name a few. The first chapter looks at the basic biology of cancer. It explains how cancer cells divide and reproduce, the genetic background of cancer cells, and discusses what makes them start and stop growing. This chapter also goes over how metabolism is affected by environmental influences and the role it plays in cancer. Next, we look at gene regulation, which is affected by amino acid metabolism.
The last chapter looks at lipid metabolism and its relationship with the immune system. Cancer Metabolism Based Therapeutics attempts to use several approaches to affect drug administration, as well as therapeutic potential and toxicity. This includes pharmacogenetics, which considers how genetics affect drug activity; pharmacodynamics, which is concerned with how chemicals interact with tissues and organs; and nicotinamide, which has been shown to reduce blood levels of lipids in tumors. Nicotinamide is also being studied in other parts of the world for its cancer-fighting ability.